glp-1 long-term side effects Your guide to Considering getting on a GLP1
Description
For patients at high risk of cardiovascular events particularly those with established atherosclerotic disease current guidelines from the ADA and ESC now favour GLP-1 receptor agonists as a preferred second-line therapy after metformin
Healthcare providers should conduct a thorough evaluation of patients reporting muscle cramps on GLP-1 therapy
The semaglutide dosage calculator can help with these conversions
None of the serious adverse events observed were considered to be reactions to exenatide
